Upcoming Deadlines for Fogarty Funding Opportunities

• Global Brain Disorders Research
  Application deadline: November 15, 2024
• Global Brain Disorders Research (AIDS)
  Application deadline: December 9, 2024
• HIV-associated Noncommunicable Diseases Research at LMIC Institutions
  Application deadline: December 9, 2024

Funding opportunities on which Fogarty is a partner:

• Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) (PAR-22-106)
  Application due date: Multiple dates, see announcement.
• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (PAR-22-109)
  Application due date: Multiple dates, see announcement.

Administrative supplements for current Fogarty grant recipients:

• Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards
  Expiration date: October 1, 2025
• Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
  Expiration date: May 8, 2026

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration:

• Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed) (RFA-AG-25-031)
  Application due date: Multiple dates, see announcement.
• Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed) (RFA-AG-25-032)
  Application due date: Multiple dates, see announcement.

NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply:

• New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed) (RFA-AI-24-068)
  Application due date: January 31, 2025
• NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional) (PAR-25-078)
  Application due date: Multiple dates, see announcement.
• Co-infection and Cancer (R01 Clinical Trial Not Allowed) (PAR-25-082)
  Application due date: Multiple dates, see announcement.
• Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses funding opportunities:
  • R21 - Clinical Trial Optional (PAR-25-115)
    Application due date: Multiple dates, see announcement.
  • R01 - Clinical Trial Optional (PAR-25-116)
    Application due date: Multiple dates, see announcement.
• Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) (RFA-DA-25-070)
  Application due date: Multiple dates, see announcement.
• Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services funding opportunities:
  • R34 Clinical Trial Optional (RFA-DA-25-070)
    Application due date: Multiple dates, see announcement.
  • R01 Clinical Trial required (RFA-DA-25-072)
    Application due date: Multiple dates, see announcement.

NIH funding opportunities for which foreign components may apply:

• TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (U54 Clinical Trial Optional) (RFA-DE-25-003)
  Application due date: January 10, 2025
• Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) (PAR-24-275)
  Application due date: Multiple dates, see announcement.
• Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required) (PAR-24-276)
  Application due date: Multiple dates, see announcement.
• Assay Validation of High Quality Markers for Clinical Studies in Cancer funding opportunities:
  • UH2/UH3 Clinical Trial Not Allowed (PAR-25-074)
    Application due date: Multiple dates, see announcement.
  • UH3 Clinical Trials Not Allowed (PAR-25-075)
    Application due date: Multiple dates, see announcement.
• NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) (PAR-25-120)
  Application due date: Multiple dates, see announcement.

Training Opportunities

NIH to host course on ethical and regulatory aspects of clinical research

This course is offered to anyone interested or involved in the ethics of clinical research with human subjects. Participants represent multiple disciplines including research teams, IRB members, physicians, psychologists, nurses, social workers, administrative staff, students, and others. The course meets Wednesday mornings from 8:30 to 11:30 a.m. ET (USA) from September 25 to November 6, 2024.

• More information
• Self-register 

Two-Part Virtual Event, NIH Grants Process Primer: Application to Award

NIH is hosting a two-part event that will provide participants with the basics to help you in your role working with the NIH grants process from application preparation to award. In Part One NIH experts will introduce participants to the NIH as an organization, key components of finding the right funding opportunity, the NIH team, application, and more. In Part Two participants will have the opportunity to view demos and engage during this next-level look at tools and systems used during the application process.

• Virtual event dates: November 13-14, 2024 at 1:00-4:00 pm ET
• Register
• The International Cancer Screening Network (ICSN) is now accepting abstract submissions for ICSN 2025, which will be held June 18-20, 2025 in Aarhus, Denmark. The theme of ICSN 2025 is "Shaping the Future of Cancer Screening." Submitters are encouraged to submit abstracts that explore topics relating to one of the 10 abstracts themes.
  • Submissions due: January 2, 2025